Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules.

Cosman D, Fanger N, Borges L, Kubin M, Chin W, Peterson L, Hsu ML.

Immunity. 1997 Aug;7(2):273-82.

2.
3.

Human cytomegalovirus, MHC class I and inhibitory signalling receptors: more questions than answers.

Cosman D, Fanger N, Borges L.

Immunol Rev. 1999 Apr;168:177-85. Review.

PMID:
10399074
4.

A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells.

Colonna M, Navarro F, Bellón T, Llano M, García P, Samaridis J, Angman L, Cella M, López-Botet M.

J Exp Med. 1997 Dec 1;186(11):1809-18.

5.

Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158).

Long EO, Barber DF, Burshtyn DN, Faure M, Peterson M, Rajagopalan S, Renard V, Sandusky M, Stebbins CC, Wagtmann N, Watzl C.

Immunol Rev. 2001 Jun;181:223-33. Review.

PMID:
11513144
6.

A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells.

Colonna M, Nakajima H, Navarro F, López-Botet M.

J Leukoc Biol. 1999 Sep;66(3):375-81. Review.

PMID:
10496306
7.
8.
9.

The leukocyte Ig-like receptor (LIR)-1 for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: analysis of LIR-1 + NK cell clones.

Vitale M, Castriconi R, Parolini S, Pende D, Hsu ML, Moretta L, Cosman D, Moretta A.

Int Immunol. 1999 Jan;11(1):29-35.

PMID:
10050671
10.

The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cells.

Prod'homme V, Griffin C, Aicheler RJ, Wang EC, McSharry BP, Rickards CR, Stanton RJ, Borysiewicz LK, López-Botet M, Wilkinson GW, Tomasec P.

J Immunol. 2007 Apr 1;178(7):4473-81.

11.

Increased expression of leukocyte Ig-like receptor-1 and activating role of UL18 in the response to cytomegalovirus infection.

Wagner CS, Riise GC, Bergström T, Kärre K, Carbone E, Berg L.

J Immunol. 2007 Mar 15;178(6):3536-43.

12.

Structure of UL18, a peptide-binding viral MHC mimic, bound to a host inhibitory receptor.

Yang Z, Bjorkman PJ.

Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10095-100. doi: 10.1073/pnas.0804551105. Epub 2008 Jul 15.

14.
15.

Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation.

Binstadt BA, Brumbaugh KM, Dick CJ, Scharenberg AM, Williams BL, Colonna M, Lanier LL, Kinet JP, Abraham RT, Leibson PJ.

Immunity. 1996 Dec;5(6):629-38.

16.

Spontaneous mutations in the human CMV HLA class I homologue UL18 affect its binding to the inhibitory receptor LIR-1/ILT2/CD85j.

Cerboni C, Achour A, Wärnmark A, Mousavi-Jazi M, Sandalova T, Hsu ML, Cosman D, Kärre K, Carbone E.

Eur J Immunol. 2006 Mar;36(3):732-41.

17.

The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes.

Fanger NA, Cosman D, Peterson L, Braddy SC, Maliszewski CR, Borges L.

Eur J Immunol. 1998 Nov;28(11):3423-34.

18.

The major SHP-1-binding, tyrosine-phosphorylated protein in macrophages is a member of the KIR/LIR family and an SHP-1 substrate.

Berg KL, Carlberg K, Rohrschneider LR, Siminovitch KA, Stanley ER.

Oncogene. 1998 Nov 12;17(19):2535-41.

19.

Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2).

Chapman TL, Heikema AP, West AP Jr, Bjorkman PJ.

Immunity. 2000 Nov;13(5):727-36.

20.

Specific recognition of the viral protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T cells mediates the non-MHC-restricted lysis of human cytomegalovirus-infected cells.

Saverino D, Ghiotto F, Merlo A, Bruno S, Battini L, Occhino M, Maffei M, Tenca C, Pileri S, Baldi L, Fabbi M, Bachi A, De Santanna A, Grossi CE, Ciccone E.

J Immunol. 2004 May 1;172(9):5629-37.

Supplemental Content

Support Center